A Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ Clavulanate
NCT01491659 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2013-09-24
Summary
It is hypothesized that Idoform plus will recuce the occurence of gastrointestinal side effects related to the use of antibiotics
Conditions
- Diarrhoea
Interventions
- DIETARY_SUPPLEMENT
-
Idoform Plus
orally once daily
- DIETARY_SUPPLEMENT
-
Placebo
orally once daily
Sponsors & Collaborators
-
Danisco/Dupont
collaborator UNKNOWN - lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2013-03-31
- Completion
- 2013-03-31
More Related Trials
-
Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years
NCT04026009 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Vaccination Against Clostridium Difficile Infection
NCT02991417 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy of IQP-MM-101 in Reducing Symptoms of Diarrhoea
NCT01969214 ·Status: COMPLETED ·Phase: NA
-
Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients
NCT02214771 ·Status: COMPLETED
-
A Comparison of Three Medications to Treat Diarrhea in Adults.
NCT00807326 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers
NCT00214461 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)
NCT04891965 ·Status: COMPLETED ·Phase: PHASE1
-
Study of CB-183,315 in Participants With Clostridium Difficile Infection
NCT01085591 ·Status: COMPLETED ·Phase: PHASE2
-
Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic Therapy
NCT04171466 ·Status: COMPLETED ·Phase: NA
-
Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study
NCT03918629 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years
NCT01706367 ·Status: COMPLETED ·Phase: PHASE1
-
Antibiotic-Associated Diarrhea and the Role of Microorganisms in the Gut
NCT04156555 ·Status: COMPLETED ·Phase: PHASE4
-
Trial Assessing the Efficacy of a Short Course of Intravenous Antibiotic Followed by Oral Antibiotic in Uncomplicated Acute Diverticulitis
NCT00917592 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-label Study Assessing Safety, Immunogenicity and Dose Response of IC84
NCT01296386 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Confirmation, Immunogenicity and Safety Study of the Clostridium Difficile Vaccine Candidate VLA84 in Healthy Adults Aged 50 Years and Older. Phase II Study
NCT02316470 ·Status: COMPLETED ·Phase: PHASE2
-
Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults
NCT02725437 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis
NCT01559545 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
NCT03110133 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age
NCT03579459 ·Status: COMPLETED ·Phase: PHASE3
-
Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea
NCT01670149 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome
NCT00269412 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Trial of a Single Dose of CRS3123
NCT01551004 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea
NCT00034294 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults
NCT01230957 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity
NCT00772954 ·Status: TERMINATED ·Phase: PHASE1